Phenoxymethylpenicillin 250mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

phenoxymethylpenicillin 250mg tablets

ivax pharmaceuticals uk ltd - phenoxymethylpenicillin potassium - oral tablet - 250mg

Phenoxymethylpenicillin 250mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

phenoxymethylpenicillin 250mg tablets

alliance healthcare (distribution) ltd - phenoxymethylpenicillin potassium - oral tablet - 250mg

Phenoxymethylpenicillin 250mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

phenoxymethylpenicillin 250mg tablets

sigma pharmaceuticals plc - phenoxymethylpenicillin potassium - oral tablet - 250mg

Cilicaine VK New Zealand - English - Medsafe (Medicines Safety Authority)

cilicaine vk

viatris limited - phenoxymethylpenicillin potassium 544.37mg equivalent to phenoxymethylpenicillin 500 mg; phenoxymethylpenicillin potassium 544.36mg equivalent to phenoxymethylpenicillin 500 mg; phenoxymethylpenicillin potassium 554.37mg equivalent to phenoxymethylpenicillin 500 mg - capsule - 500 mg - active: phenoxymethylpenicillin potassium 544.37mg equivalent to phenoxymethylpenicillin 500 mg excipient: gelatin magnesium stearate active: phenoxymethylpenicillin potassium 544.36mg equivalent to phenoxymethylpenicillin 500 mg excipient: capsugel orange op.c027 gelatin iron oxide red magnesium stearate titanium dioxide active: phenoxymethylpenicillin potassium 554.37mg equivalent to phenoxymethylpenicillin 500 mg excipient: maroon capsule acg associated capsules pvt. ltd magnesium stearate - when oral therapy is required in the treatment of mild to moderately severe infections due to penicillin sensitive organisms. therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. for prophylactic use in recurrent streptococcal infections including the prevention of recurrence following rheumatic fever and/or sydenham's chorea and to prevent bacterial endocarditis in patients with rheumatic fever and/or congenital heart disease who are about to undergo dental or upper respiratory surgery or instrumentation.